Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
AboutMethodSourcesNewsletter
Insider tradingForm 4

Attovia Therapeutics, Inc. (ATTO) Insider Trading

6 open-market trades reported since Aug 13, 2026: 4 purchases worth $20.6M and 2 sales worth $4.50M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Goldman Sachs Group IncOther2$10.3M1$2.25MAug 13, 2026
Colin WalshDirector2$10.3M1$2.25MAug 13, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

ATTO insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Aug 13Aug 6Goldman Sachs Group IncOtherOther (ind.)▲ BUY500,00017.00$8.50M+20%Form 4 ↗
Aug 13Aug 6Colin WalshDirectorDirector (ind.)▲ BUY500,00017.00$8.50M+20%Form 4 ↗
Aug 13Aug 5Goldman Sachs Group IncOtherOther (ind.)▼ SELL105,80721.28$2.25M−58%Form 4 ↗
Aug 13Aug 5Colin WalshDirectorDirector (ind.)▼ SELL105,80721.28$2.25M−58%Form 4 ↗
Aug 13Aug 5Goldman Sachs Group IncOtherOther (ind.)▲ BUY85,00021.00$1.78MNewForm 4 ↗
Aug 13Aug 5Colin WalshDirectorDirector (ind.)▲ BUY85,00021.00$1.78MNewForm 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings